Diabetes

The American College of Physicians' oral medication guideline for treating type 2 diabetes is the first update since 2012, and it reflects many new medications that have received FDA approval since that time.

As 2016 drew to a close, The American Journal of Managed Care (AJMC)® polled readers on what was, in their opinion, the biggest healthcare story of the year. Runners-up included drug pricing drama, Medicare policy announcements, and more, but the top answer by far was the news story that sent shockwaves throughout the healthcare industry and around the world.

A glimpse at the top 5 articles from The American Journal of Managed Care's® conference coverage that caught reader attention in 2016.

Why a mobile health coaching company sees its move from per member per month to outcomes-based payment as the right thing-for employers and for consumers.

Evaluation of US healthcare data between 1996 and 2013 found that 20 conditions accounted for half of all spending in the United States, with diabetes leading the way.

Important updates of the past year sought to recognize the importance of obesity care and the need to better integrate behavioral health into diabetes care.

The American Journal of Managed Care provides coverage from its live meetings, the ACO & Emerging Healthcare Delivery Coalition, Patient-Centered Oncology Care, and Patient-Centered Diabetes Care.

As 2016 draws to a close, here’s a look at the top 5 news articles that captured reader interest on AJMC.com.

Diabetes and obesity are major public health priorities that are highly associated with environmental factors and correlated with the availability of open space in neighborhoods and communities.

This week, the top managed care stories included CMS announcing more mandatory bundled payment models and a new track in the Medicare Shared Savings Program, the FDA approving a new use for Dexcom's continuous glucose monitor, and a greater emphasis on lifestyle management in the American Diabetes Association's care standards.

There's no shortage of reader interest in Afrezza-the inhaled, meal-time insulin from MannKind-despite reports from Wall Street that the prescription count is climbing slowly.

The study drug targets both the SGLT1 protein, which affects blood glucose absorption in the gastrointestinal tract, and the SGLT2 protein, which affects reabsorption by the kidney.

A study that purported to doubt on the scientific evidence supporting current sugar intake guidelines has been criticized for its funding source: the sugar, food, and beverage industries.

Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016.

The expanded use for Novo Nordisk's new basal insulin comes 15 months after the initial FDA approval.

On the day of the approval, top FDA and CMS officials write in JAMA of the need to share data for better healthcare delivery.

The findings come as CMS targets cardiac procedures in both its hospital readmission reduction program and in a bundled payment model set to take effect July 1, 2017.

Along with the peer-review research, journal articles, and news coverage, The American Journal of Managed Careâ„¢ (AJMCâ„¢) has a robust multimedia component that brings together stakeholders from across the healthcare industry to discuss important topics in the world of managed care and delve deeper into topics.

The recommendation to limit long periods of sitting comes after multiple studies show how it affects blood glucose management. ADA also gives providers charts to help them understand the cost of different therapies.

Providers who treat people with diabetes have observed the phenomenon of low-income patients who need a lot of medical care not having enough information to choose policies that meet their needs.

This week, the top stories in managed care include President Barack Obama signing the 21st Century Cures Act into law, findings from the CDC that opioid abuse has reduced life expectancy for Americans, and CVS announced a new program to lower costs for patients with diabetes.

A chronic disease management company presents promising preliminary results from their remote intensive behavioral counseling intervention, aimed at addressing type 2 diabetes.

AADE16 Conference Coverage

The American Journal of Managed Care and the American Association of Diabetes Educators have collaborated on a special joint issue of Evidence-Based Diabetes Management, which focuses on the growing evidence for payer coverage of Diabetes Self-Management Education and Support and the Diabetes Prevention Program.

Glycemic control in patients with type 2 diabetes was improved through a shared medical appointment program focusing on lifestyle education and behavior change.

A leading diabetes educator discusses how the role of nutrition has evolved and how payers can do more to promote the role of education in helping patients improve their diets.

Since insurers began pulling out of the individual market in many states, CMS has vowed to crack down on practices that drive up costs.

CVS' Transform Diabetes Care program calls for the use of analytics to identify opportunities for behavioral change or new treatment. The pharmacy benefit manager says it hopes to save clients between $3000 and $5000 annually per member with diabetes.

A recent report from the Government Accountability Office mostly concurs with CMS on a dispute over problems with the Medicare competitive bidding program, following an explosive study in Diabetes Care that found beneficiaries lost access to key supplies.

Diabetes educators are well-positioned to help accountable care organizations meet their business, healthcare, and financial goals. The emphasis on primary care in treating chronic disease calls for an increased emphasis on diabetes educators to achieve better healthcare outcomes in a cost-effective manner.